わかもと製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4512/E00928 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/01/04 | 日証協 | 81,700株 | -0.12% | 9,100株 | -80.43% | 152,534株 | +0.59% | 4,600株 | -33.22% |
2018/12/28 | 日証協 | 81,800株 | +14.41% | 46,500株 | +511.84% | 151,634株 | 0% | 6,888株 | -36.81% |
2018/12/21 | 日証協 | 71,500株 | -13.86% | 7,600株 | -79.23% | 151,634株 | +16.52% | 10,900株 | -71.76% |
2018/12/14 | 日証協 | 83,000株 | +4.8% | 36,600株 | -6.63% | 130,134株 | +0.7% | 38,600株 | +135.19% |
2018/12/07 | 日証協 | 79,200株 | +0.36% | 39,200株 | +2.02% | 129,234株 | -1.82% | 16,412株 | +33.43% |
2018/11/30 | 日証協 | 78,912株 | +8.4% | 38,424株 | +154.46% | 131,634株 | -21.57% | 12,300株 | +83.58% |
2018/11/22 | 日証協 | 72,800株 | +3.41% | 15,100株 | -53.25% | 167,834株 | -30.8% | 6,700株 | -66.16% |
2018/11/16 | 日証協 | 70,400株 | +3.07% | 32,300株 | -48.57% | 242,534株 | +48.04% | 19,800株 | -83.18% |
2018/11/09 | 日証協 | 68,300株 | -8.08% | 62,800株 | +7.35% | 163,834株 | +40.71% | 117,700株 | +105.41% |
2018/11/02 | 日証協 | 74,300株 | +2.77% | 58,500株 | +83.96% | 116,434株 | -39.53% | 57,300株 | -43.38% |
2018/10/26 | 日証協 | 72,300株 | -32.62% | 31,800株 | -8.09% | 192,534株 | +52.4% | 101,200株 | +251.39% |
2018/10/19 | 日証協 | 107,300株 | -19.63% | 34,600株 | +4.85% | 126,334株 | -6.73% | 28,800株 | +3.23% |
2018/10/12 | 日証協 | 133,500株 | +4.79% | 33,000株 | +30.43% | 135,444株 | +8.32% | 27,900株 | +206.22% |
2018/10/05 | 日証協 | 127,400株 | -1.09% | 25,300株 | -16.78% | 125,044株 | +20.79% | 9,111株 | -27.11% |
2018/09/28 | 日証協 | 128,800株 | +6.1% | 30,400株 | +128.57% | 103,518株 | -17.73% | 12,500株 | +26.26% |
2018/09/21 | 日証協 | 121,400株 | +11.27% | 13,300株 | +17.55% | 125,833株 | -0.17% | 9,900株 | +3.12% |
2018/09/14 | 日証協 | 109,100株 | +2.63% | 11,314株 | +49.77% | 126,044株 | +0.24% | 9,600株 | +17.07% |
2018/09/07 | 日証協 | 106,300株 | -1.94% | 7,554株 | +220.9% | 125,744株 | +1.13% | 8,200株 | +290.48% |
2018/08/31 | 日証協 | 108,400株 | -1.63% | 2,354株 | -55.16% | 124,344株 | -0.24% | 2,100株 | -60.38% |
※株式分割は考慮していませんのでご注意ください。
Page Top